ZANIDATAMAB - Food and Drug Administration
- Set ID
- f2c3e67f-5518-4f2b-a6f6-2bbd4cb0c983
- Type
- Indexing - product concept
- Effective date
- 2025-07-22
- Version
- 1
- Source
- DailyMed source
Mapped DailyMed Labels#
| Label | Relation | Manufacturer | Effective |
|---|---|---|---|
| These highlights do not include all the information needed to use ZIIHERA safely and effectively. See full prescribing information for ZIIHERA. ZIIHERA ® (zanidatamab‑hrii) for injection, for intravenous use Initial U.S. Approval: 2024 | Product name | Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals Ireland Limited | WuXi Biologics Co., Ltd. | Almac Pharma Services LLC | 2026-08-24 |
| These highlights do not include all the information needed to use ZIIHERA safely and effectively. See full prescribing information for ZIIHERA. ZIIHERA ® (zanidatamab‑hrii) for injection, for intravenous use. Initial U.S. Approval: 2024 | Product name | Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals Ireland Limited | WuXi Biologics Co., Ltd. | Almac Pharma Services LLC | 2025-07-01 |